Roflumilast 500 mcg tablet

Roflumilast 500 mcg tablet is unique because it is an oral tablet rather than an inhaled medication. It works systematically to lower the levels of pro-inflammatory substances in the lung tissue, which helps prevent the structural damage and mucus overproduction typical of severe COPD.

Key Clinical Benefits

• Reduces Flare-Ups: Significantly lowers the risk of COPD exacerbations that lead to hospitalization.

• Non-Steroid Inflammation Control: Provides a different pathway for reducing swelling in the airways without the systemic side effects of oral corticosteroids.

• Improved Lung Function: Helps stabilize the FEV1 (Forced Expiratory Volume) in patients with a history of frequent bronchitis episodes.

• Complementary Therapy: Works effectively when added to existing treatment regimens involving long-acting bronchodilators (LABA/LAMA).

Administration & Safety Protocols

1. Consistent Dosing: Take one 500 mcg tablet once daily, at the same time every day, with or without food.

2. Not a Rescue Inhaler: Roflumilast is NOT for sudden attacks of breathlessness. Always keep your fast-acting rescue inhaler with you for emergencies.

3. Weight Monitoring: This medication can cause weight loss. Monitor your weight regularly and report any significant, unexplained loss to your doctor.

4. Mental Health: In rare cases, PDE4 inhibitors can affect mood. Inform your physician if you have a history of depression or if you notice new feelings of anxiety or suicidal thoughts.

5. Liver Health: Roflumilast should not be used by patients with moderate to severe liver impairment.